Arcutis Biotherapeutics, Inc. (ARQT)
Nasdaq: ARQT · Pharmaceutical Preparations · Westlake Village, CA · filing with the SEC since 2019
Who runs Arcutis Biotherapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
6
of 15 people with a filing in the last fifteen months
Directors reporting now
9
31 people on the record since 2020
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Burnett Patrick | EVP, Chief Medical Officer | Aug 2020 | Nov 4, 2026 | 17 · $2.0M |
| Matsuda Masaru | EVP, Chief Legal Officer | Jan 2022 | Nov 4, 2026 | 18 · $3.4M |
| Watanabe Todd Franklin | See Remarks | Jan 2020 | Nov 4, 2026 | 8 · $3.3M |
| Welgus Howard G. | Chief Medical Officer | Jan 2020 | Oct 19, 2026 | 12 · $2.1M |
| Vairavan Latha | SVP Chief Financial Officer | May 2025 | May 13, 2026 | 5 · $100,000 |
| Edwards Larry Todd | Reporting Person's title: EVP, Chief Commercial Officer | Sep 2023 | Mar 3, 2026 | 4 · $900,000 |
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Scott Robert A | director | Oct 2026 | Oct 28, 2026 | none |
| Curran Terrie | director | Nov 2020 | Aug 28, 2026 | 3 · $1.0M |
| Peetz Christopher | director | Jul 2026 | Jul 17, 2026 | none |
| Lin Sue-Jean | director | Jun 2021 | Jun 17, 2026 | 2 · $900,000 |
| Heron Patrick J | director | Jan 2020 | Jun 12, 2026 | none |
| Gilbert Halley E | director | May 2020 | Jun 9, 2026 | 1 · $500,000 |
| Krishnamohan Neha | director | Sep 2022 | Jun 9, 2026 | 2 · $900,000 |
| Leonard Keith R | director | Sep 2021 | Jun 9, 2026 | 1 · $1.0M |
| Munshi Amit | director | Dec 2025 | Jun 9, 2026 | none |
Earlier names on the record26, newest filing first
Chaudhuri Bhaskar · director · last filing Jun 2025Topper David Joseph · officer · last filing Apr 2025Moore Matthew Richard · officer · last filing May 2024Smither John W · officer · last filing Feb 2024Fhm Life Sciences Viii, L.L.C. · 10% owner · last filing Oct 2023Fhm Life Sciences Viii, L.P. · 10% owner · last filing Oct 2023Frazier Life Sciences Viii, L.P. · 10% owner · last filing Oct 2023Topper James N · 10% owner · last filing Oct 2023Burrows Scott L · officer · last filing Mar 2023Lock Kenneth A. · officer · last filing Mar 2023Osborne David W · officer · last filing Mar 2023Turney Patricia A. · officer · last filing Mar 2023Orbimed Advisors LLC · director · last filing Jun 2022Orbimed Capital Gp Vii LLC · director · last filing Jun 2022Orbimed Capital LLC · director · last filing Jun 2022Turner Joseph L · director · last filing Jun 2022Sun Ricky · director · last filing Jun 2021Silverstein Jonathan · director · last filing Oct 2020Estes Daniel · director · last filing Mar 2020Bain Capital Life Sciences Fund, L.P. · 10% owner · last filing Feb 2020Bain Capital Life Sciences Investors, LLC · 10% owner · last filing Feb 2020Bain Capital Life Sciences Partners, LP · 10% owner · last filing Feb 2020Bcip Life Sciences Associates, LP · 10% owner · last filing Feb 2020Koppel Adam · 10% owner · last filing Feb 2020Schwartz Jeffrey Lawrence · 10% owner · last filing Feb 2020Asam Alexander · director · last filing Jan 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.